Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9α

Peptides

Volumn 26, Issue 7, 2005, Pages 1235-1247

  Mueller, Sylvia ^a   Gothe, Rita ^a   Siems, Wolf Dieter ^b   Vietinghoff, Gabriele ^c   Paegelow, Inge ^c   Reissmann, Siegmund ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Angiotensin I converting enzyme; Arachidonic acid; Bradykinin; Bradykinin potentiating peptide; Ca2+ influx; Chemotaxis; Inositol phosphate; Polymorphonuclear leukocytes; Potentiation; Protein phosphatases; Smooth muscle contraction

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; BRADYKININ DERIVATIVE; BRADYKININ POTENTIATING NONAPEPTIDE 9ALPHA; BRADYKININ POTENTIATING NONPEPTIDE 9ALPHA [1 PROLINE]; CALCIUM CHANNEL; CALYCULIN A; INOSITOL PHOSPHATE; J 526; J 527; LANTHANUM; PHOSPHATASE; RAMIPRILAT; TEPROTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL STRAIN COS7; CHEMOTAXIS; ENZYME DEGRADATION; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; IMMUNE SYSTEM; IMMUNOCOMPETENCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; CALCIUM; CERCOPITHECUS AETHIOPS; COS CELLS; DRUG SYNERGISM; GUINEA PIGS; HUMANS; INOSITOL PHOSPHATES; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PHOSPHOPROTEIN PHOSPHATASE; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; TEPROTIDE;

EID: 20444417455     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.03.046     Document Type: Article

References (81)

1. S. AbdAlla, H. Lother, and U. Quitterer AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration Nature 407 6800 2000 94 98
2. A. Adomeit, A. Graness, S. Gross, K. Seedorf, R. Wetzker, and C. Liebmann Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation Mol Cell Biol 19 8 1999 5289 5297
3. A.A. Akchunov, Z. Golubenko, and N. Sosnina Isolation and characterization of biological properties of inhibitors angiotensin-1-converting enzyme from the spider venom Latrodectus tredecimguttatus Agents Actions Suppl 38 Pt 1 1992 469 474
4. 2 receptor antagonist, FR165649, and agonist FR190997 Br J Pharmacol 124 3 1998 441 446
5. W. Auerswald, and W. Doleschel On the potentiation of kinins by sulfhydrylic compounds Arch Int Pharmacodyn Ther 168 1 1967 188 198
6. D.B. Brunner, G. Desponds, J. Biollaz, I. Keller, F. Ferber, and H. Gavras Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects Br J Clin Pharmacol 11 5 1981 461 467
7. D. Chaturvedi, E. Huelar, M. Gunthorpe, M. Gofman, D.S. Krapf, and E. Apostol Bradykinin analogs as inhibitors of angiotensin-converting enzyme Pept Res 6 6 1993 308 312
8. C.W. Chi, S.Z. Wang, L.G. Xu, M.Y. Wang, S.S. Lo, and W.D. Huang Structure-function studies on the bradykinin potentiating peptide from Chinese snake venom (Agkistrodon halys Pallas) Peptides 6 Suppl 3 1985 339 342
9. A.C. Cintra, C.A. Vieira, and J.R. Giglio Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom J Protein Chem 9 2 1990 221 227
10. M. Cirstea Potentiation of some bradykinin effects by thiol compounds Br J Pharmacol 25 2 1965 405 410
11. J. Cotton, M.A. Hayashi, P. Cuniasse, G. Vazeux, D. Ianzer, and A.C. De Camargo Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides Biochemistry 41 19 2002 6065 6071
12. D.W. Cushman, H.S. Cheung, E.F. Sabo, and M.A. Ondetti Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids Biochemistry 16 25 1977 5484 5491
13. D.W. Cushman, J. Pluscec, N.J. Williams, E.R. Weaver, E.F. Sabo, and O. Kocy Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom Experientia 29 8 1973 1032 1035
14. P.A. Deddish, B. Marcic, H.L. Jackman, H.Z. Wang, R.A. Skidgel, and E.G. Erdos N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE Hypertension 31 4 1998 912 9177
15. P.A. Deddish, B.M. Marcic, F. Tan, H.L. Jackman, Z. Chen, and E.G. Erdos Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor Hypertension 39 2 Pt 2 2002 619 623
16. 2-agonists with improved degradation stability Immunopharmacology 45 1-3 1999 199 205
17. A. Dendorfer, S. Reissmann, S. Wolfrum, W. Raasch, and P. Dominiak Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation Hypertension 38 1 2001 142 146
18. J. Duchene, J.P. Schanstra, C. Pecher, A. Pizard, C. Susini, and J.P. Esteve A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation J Biol Chem 277 43 2002 40375 40383
19. E.G. Erdos, and B.M. Marcic Kinins, receptors, kininases and inhibitors - where did they lead us? Biol Chem 382 1 2001 43 47
20. S.G. Farmer, S.J. Powell, D.E. Wilkins, and A. Graham Cloning, sequencing and functional expression of a guinea pig lung bradykinin B2 receptor Eur J Pharmacol 346 2/3 1998 291 298
21. L.A. Ferreira, E.W. Alves, and O.B. Henriques Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom Toxicon 31 8 1993 941 947
22. L.A. Ferreira, W.E. Alves, M.S. Lucas, and G.G. Habermehl Isolation and characterization of a bradykinin potentiating peptide (BPP-S) isolated from Scaptocosa raptoria venom Toxicon 34 5 1996 599 603
23. L.A. Ferreira, A. Galle, M. Raida, M. Schrader, I. Lebrun, and G. Habermehl Isolation: analysis and properties of three bradykinin-potentiating peptides (BPP-II, BPP-III, and BPP-V) from Bothrops neuwiedi venom J Protein Chem 17 3 1998 285 289
24. L.A. Ferreira, O.B. Henriques, I. Lebrun, M.B. Batista, B.C. Prezoto, and A.S. Andreoni A new bradykinin-potentiating peptide (peptide P) isolated from the venom of Bothrops jararacussu (jararacucu tapete, urutu dourado) Toxicon 30 1 1992 33 40
25. L.A. Ferreira, T. Mollring, F.L. Lebrun, M. Raida, R. Znottka, and G.G. Habermehl Structure and effects of a kinin potentiating fraction F (AppF) isolated from Agkistrodon piscivorus piscivorus venom Toxicon 33 10 1995 1313 1319
26. S.H. Ferreira A bradykinin-potentiating factor (Bpf) present in the venom of Bothrops jararaca Br J Pharmacol 24 1965 163 169
27. S.H. Ferreira, D.C. Bartelt, and L.J. Greene Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom Biochemistry 9 13 1970 2583 2593
28. X. Ferry, S. Brehin, R. Kamel, and Y. Landry G protein-dependent activation of mast cell by peptides and basic secretagogues Peptides 23 8 2002 1507 1515
29. J.P. Fortin, F. Gobeil Jr., A. Adam, D. Regoli, and F. Marceau Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor? Am J Physiol Heart Circ Physiol 285 1 2003 H277 H282
30. 2 J Med Chem 36 22 1993 3481 3483
31. F. Gobeil Jr., S. Halle, P.A. Blais, and D. Regoli Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin Can J Physiol Pharmacol 80 2 2002 153 163
32. R. Gothe, L. Seyfahrt, C. Schuhmann, I. Agricola, S. Reissmann, and A. Lifferth Combination of allyl protection and HYCRAM™-linker technology for the synthesis of peptides with problematical amino acids and sequences J Prakt Chem 341 1999 369 377
33. M. Hecker, A.T. Bara, and R. Busse Potentiation of the biological efficacy of bradykinin by ACE inhibitors: a shift in the affinity of the B2 receptor? Immunopharmacology 33 1-3 1996 93 94
34. O.B. Henriques, R.B. de Deus, and R.A. Santos Bradykinin potentiating peptides isolated from alpha-casein tryptic hydrolysate Biochem Pharmacol 36 1 1987 182 184
35. S. Higuchi, N. Murayama, K. Saguchi, H. Ohi, Y. Fujita, and A.C. Camargo Bradykinin-potentiating peptides and C-type natriuretic peptides from snake venom Immunopharmacology 44 1/2 1999 129 135
36. D. Ianzer, K. Konno, R. Marques-Porto, F.C. Vieira Portaro, R. Stöcklin, and A.C. Martins de Camargo Identification of five new bradykinin potentiating peptides (BPPs) from Bothrops jararaca crude venom by using electrospray ionization tandem mass spectrometry after a two-step liquid chromatography Peptides 25 7 2004 1085 1092
37. T. Ignjatovic, F. Tan, V. Brovkovych, R.A. Skidgel, and E.G. Erdos Activation of bradykinin B1 receptor by ACE inhibitors Int Immunopharmacol 2 13/14 2002 1787 1793
38. V.T. Ivanov, A.A. Karelin, M.M. Philippova, I.V. Nazimov, and V.Z. Pletnev Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool Biopolymers 43 1997 171 188
39. H. Kato, and T. Suzuki Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffii Experientia 25 7 1969 694 695
40. H. Kato, and T. Suzuki Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C Biochemistry 10 6 1971 972 980
41. S. Klutchko, C.J. Blankley, R.W. Fleming, J.M. Hinkley, A.E. Werner, and I. Nordin Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types J Med Chem 29 10 1986 1953 1961
42. P. Koehne, C. Schaper, K. Graf, and G. Kunkel Neutral endopeptidase 24.11: its physiologic and possibly pathophysiologic role in inflammation with special effect on respiratory inflammation Allergy 53 11 1998 1023 1042
43. A. Kudoh, E. Kudoh, H. Katagai, and T. Takazawa Insulin potentiates bradykinin-induced inositol 1,4,5-triphosphate in neonatal rat cardiomyocytes J Cardiovasc Pharmacol 39 5 2002 621 627
44. V.M. L'vov, and L.Y. Yukel'son Bradykinin-potentiating peptides from Echis multisquamatus venom Khim Prir Soedin 1 1995 435 440
45. A. Ladram, J.J. Montagne, M. Bulant, and P. Nicolas Analysis of structural requirements for TRH-potentiating peptide receptor binding by analogue design Peptides 15 3 1994 429 433
46. I. Lebrun, F.L. Lebrun, O.B. Henriques, A.K. Carmona, L. Juliano, and A.C. Camargo Isolation and characterization of a new bradykinin potentiating octapeptide from gamma-casein Can J Physiol Pharmacol 73 1 1995 85 91
47. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, and M.A. Berne Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 6965 2003 450 454
48. C. Liebmann G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts Curr Pharm Des 10 16 2004 1937 1958
49. B. Marcic, P.A. Deddish, H.L. Jackman, and E.G. Erdos Enhancement of bradykinin and resensitization of its B2 receptor Hypertension 33 3 1999 835 843
50. B. Marcic, P.A. Deddish, R.A. Skidgel, E.G. Erdos, R.D. Minshall, and F. Tan Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors J Biol Chem 275 21 2000 16110 16118
51. T. Matsui, C.H. Li, and Y. Osajima Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ J Pept Sci 5 7 1999 289 297
52. A.R. Meki, A.Y. Nassar, and H. Rochat A bradykinin-potentiating peptide (peptide K12) isolated from the venom of Egyptian scorpion Buthus occitanus Peptides 16 8 1995 1359 1365
53. R.D. Minshall, S.J. Nedumgottil, R. Igic, E.G. Erdos, and S.F. Rabito Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum Peptides 21 8 2000 1257 1264
54. R.D. Minshall, F. Tan, F. Nakamura, S.F. Rabito, R.P. Becker, and B. Marcic Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells Circ Res 81 5 1997 848 856
55. H.M. Molina, A.K. Carmona, M. Kouyoumdjian, D.R. Borges, and L. Juliano Liver bradykinin-inactivating-endopeptidase is similar to the metalloendopeptidase (EC 3.4.24.15) Immunopharmacology 32 1-3 1996 176 179
56. S. Muller, A. Adomeit, R. Kaufmann, H. Appelhans, H. Passow, and S. Reissmann Expression and functional characterization of a pHis-tagged human bradykinin B2 receptor in COS-7 cells Biol Chem 381 4 2000 343 347
57. S. Mueller, C. Liebmann, and S. Reissmann Intramolecular signal transduction by the bradykinin B2 receptor Int Immunopharmacol 2 13/14 2002 1763 1770
58. M.U. Norman, R.A. Lew, A.I. Smith, and M.J. Hickey Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature Am J Physiol Heart Circ Physiol 284 6 2003 1942 1948
59. M.A. Ondetti, N.J. Williams, E.F. Sabo, J. Pluscec, E.R. Weaver, and O. Kocy Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis Biochemistry 10 22 1971 4033 4039
60. B. Ongali, S. Buck Hde, F. Cloutier, F. Legault, D. Regoli, and C. Lambert Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord Am J Physiol Heart Circ Physiol 284 6 2003 H1949 H1958
61. I. Paegelow Nachweis chemotaktischer Faktoren 1991 Gustav Fischer Verlag Jena
62. I. Paegelow, S. Trzeczak, S. Bockmann, and G. Vietinghoff Migratory responses of polymorphonuclear leukocytes to kinin peptides Pharmacology 66 3 2002 153 161
63. A. Papapetropoulos, J.W. Ryan, A. Antonov, R. Virmani, F.D. Kolodgie, and R.G. Gerrity Human aortic endothelial cell aminopeptidase N Immunopharmacology 32 1-3 1996 153 156
64. A.A. Patchett, E. Harris, E.W. Tristram, M.J. Wyvratt, M.T. Wu, and D. Taub A new class of angiotensin-converting enzyme inhibitors Nature 288 5788 1980 280 283
65. R.D. Paula, C.V. Lima, R.R. Britto, M.J. Campagnole-Santos, M.C. Khosla, and R.A. Santos Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides Peptides 20 4 1999 493 500
66. J.M. Piot, Q. Zhao, D. Guillochon, G. Ricart, and D. Thomas Isolation and characterization of a bradykinin-potentiating peptide from a bovine peptic hemoglobin hydrolysate FEBS Lett 299 1 1992 75 79
67. J.W. Ryan, A. Papapetropoulos, H. Ju, N.D. Denslow, A. Antonov, and R. Virmani Aminopeptidase P is disposed on human endothelial cells Immunopharmacology 32 1-3 1996 149 152
68. C. Schumann, L. Seyfarth, G. Greiner, I. Paegelow, and S. Reissmann Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues J Pept Res 60 2 2002 128 140
69. 125I]ANF binding to FRTL-5 rat thyroid cells by increasing ANF receptor affinity Peptides 15 7 1994 1249 1253
70. W.E. Siems, G. Heder, and N.W. Komissarowa Procedure for the determination of angiotensin converting enzyme Z Med Lab Diagn 26 4 1985 232 234
71. R.A. Skidgel, and E.G. Erdos Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies Peptides 25 3 2004 521 525
72. R.A. Skidgel, G.B. McGwire, and X.Y. Li Membrane anchoring and release of carboxypeptidase M: implications for extracellular hydrolysis of peptide hormones Immunopharmacology 32 1-3 1996 48 52
73. N.A. Sosnina, Z. Golubenko, A.A. Akhunov, E.V. Kugaevskaia, E. Eliseeva Iu, and V.N. Orekhovich Bradykinin-potentiating peptides from the spider Latrodectus tredecimguttatus - inhibitors of carboxycathepsin and of a preparation of karakurt venom kininase Dokl Akad Nauk SSSR 315 1 1990 236 239
74. W. Steinmann The E.K. Frey-E. Werle Foundation of the Henning L. Voigt Family Award ceremony Braz J Med Biol Res 27 8 1994 1687 1692
75. V. Teetz, R. Geiger, R. Henning, and H. Urbach Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3- phenylpropyl]-l-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) Arzneimittelforschung 34 10B 1984 1399 1401
76. B. Tom, R. de Vries, P.R. Saxena, and A.H. Danser Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade Hypertension 38 1 2001 95 99
77. J.G. Ufkes, P.N. Aarsen, and C. van der Meer The mechanism of action of two bradykinin-potentiating peptides on isolated smooth muscle Eur J Pharmacol 44 2 1977 89 97
78. J.G. Ufkes, B.J. Visser, G. Heuver, and C. Van der Meer Structure-activity relationships of bradykinin potentiating peptides Eur J Pharmacol 50 2 1978 119 122
79. L. Wei, F. Alhenc-Gelas, P. Corvol, and E. Clauser The two homologous domains of human angiotensin I-converting enzyme are both catalytically active J Biol Chem 266 14 1991 9002 9008
80. K. Yamafuji, Y. Taniguchi, and E. Sakamoto The thiol enzyme from rat spleen that produces bradykinin potentiating peptide from rat plasma Immunopharmacology 32 1-3 1996 157 159
81. Q. Zhao, I. Garreau, F. Sannier, and J.M. Piot Opioid peptides derived from hemoglobin: hemorphins Biopolymers 43 2 1997 75 98